Retrieved March 10, 2026, from
Any GLP-1 receptor agonist can cause burping because they all share the same mechanism of slowing gastric emptying
About TRIUMPH-2, TRIUMPH-3, and the TRIUMPH clinical trial program TRIUMPH-2 (NCT05929079) is a Phase 3, 80-week, randomized, double-blind, and placebo-controlled trial under a basket design investigating the efficacy and safety of retatrutide once weekly compared with placebo in participants with type 2 diabetes and obesity or overweight
GLP-1 medication works by: Slowing down the food travelling through your digestive system so you feel more full
For example, in one letter the following was flagged as offending language, despite not naming the branded products: Doctors frequently recommend Compounded Tirzepatide or Compounded Semaglutide, both of which are GLP-1 agonists with the same active ingredient as the brand name medications. In another letter, the only offending language was: Clinically proven weight loss treatments. The FDA said this language implies that [the sellers] products are the same as an FDA-approved product when they are not. Whats Next
At the latest CAGNY conference, General Mills stated Were innovating to meet evolving consumer weight management and nutrition needs by packing more protein into our Annies Mac and Cheese through a new Supramax offering, launching a protein-forward Progresso soup line and bringing lower sugar offerings to our Betty Crocker cakes, cookies and brownies. And retailers are also stepping in with content and advocacy
